Baldwin Insurance vs CorVel
BWIN and CRVL side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BWIN and CRVL compare
Baldwin Insurance and CorVel are about the same size, with market caps of $4.5B and $4.3B.
Baldwin Insurance grew revenue faster over the last twelve months (24.6% versus 8.3% for CorVel).
CorVel keeps more of each dollar of sales as profit, with a net margin of 12.0% compared with −6.5% at Baldwin Insurance.
CorVel scores higher on the StockData Score (12 against 5 for Baldwin Insurance), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BWIN | CRVL |
|---|---|---|
| Size and price | ||
| Market cap | $4.5B | $4.3B |
| Share price | $32.05 | $85.69 |
| Change, 1 year | 15.2% | 11.0% |
| Change, 5 years | −17.1% | 31.6% |
| Beta (5Y) | 1.13 | 0.68 |
| Employees | 5,000 | 5,239 |
| StockData Score | ||
| Total score | 5 | 12 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 36.0× |
| P/S | 2.4× (better) | 4.3× |
| P/B | 5.2× (better) | 10.1× |
| EV/EBITDA | 97.2× | 20.8× (better) |
| P/FCF | 88.2× | 33.9× (better) |
| PEG | – | 1.86 |
| FCF yield | 1.1% | 3.0% (better) |
| Fair value | – | $91.68 |
| Margin of safety | – | 6.5% |
| Growth | ||
| Revenue growth (TTM) | 24.6% (better) | 8.3% |
| Revenue growth, 5Y average | – | 11.6% |
| Net income growth (TTM) | – | 15.4% |
| EPS growth (TTM) | – | 17.2% |
| EPS growth, 5Y average | – | 20.3% |
| Profitability | ||
| Gross margin | – | 25.5% |
| Operating margin | −9.0% | – |
| Net margin | −6.5% | 12.0% (better) |
| FCF margin | 2.7% | 12.6% (better) |
| Return on equity | −16.3% | 30.6% (better) |
| Return on invested capital | −26.5% | – |
| Financial health | ||
| Debt / equity | 0.02 | – |
| Net debt / EBITDA | −3.41 | – |
| Current ratio | 0.89 | 2.02 (better) |
| Altman Z-score | 0.66 | 13.15 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 1.7% |
| Shareholder yield | 0.00% | 1.7% (better) |
| Ownership | ||
| Held by institutions | 64.1% | 55.1% |
| Held by insiders | 17.8% | 40.2% |
| Insider net buying, 12 months | −$12.2M (better) | −$20.9M |
| Short interest, % of float | 5.2% | 3.6% |
Go deeper
- BWIN stock overview
- BWIN income statement
- BWIN valuation and score
- CRVL stock overview
- CRVL income statement
- CRVL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.